Sumitomo Seika Chemicals Company, Limited.

TSE:4008.T

5210 (JPY) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 142,986143,041115,583103,25499,701109,634105,88398,85787,00392,69894,91170,59168,19464,67256,52564,73762,25554,47146,73741,716
Cost of Revenue 114,979112,90589,43478,07877,31685,19281,02074,10466,03872,10473,93054,85752,66148,18344,00452,48747,02339,73334,18031,219
Gross Profit 28,00730,13626,14925,17622,38524,44224,86324,75320,96520,59420,98115,73415,53316,48912,52112,25015,23214,73812,55710,497
Gross Profit Ratio 0.1960.2110.2260.2440.2250.2230.2350.250.2410.2220.2210.2230.2280.2550.2220.1890.2450.2710.2690.252
Reseach & Development Expenses 2,7112,6702,5902,8813,1772,8962,7152,3832,2842,2512,0872,1272,4542,6112,3851,9391,5821,6021,3661,526
General & Administrative Expenses 5,6088,2847,2044,3133,5553,8733,8843,5772,9462,8882,9092,3662,5292,3172,1632,4511,9591,6981,2681,231
Selling & Marketing Expenses 5,6088,2847,2044,3133,5553,8733,8843,5772,9462,8882,9092,36600000000
SG&A 15,7668,2847,2044,3133,5553,8733,8843,5772,9462,8882,9092,3662,5292,3172,1632,4511,9591,6981,2681,231
Other Expenses -1115724230818516315640-41-19821262,540143-8-212-96-31
Operating Expenses 18,47719,67618,07315,07214,60715,36615,12414,20713,55713,33912,92111,5477,4287,4687,0266,7466,1265,8675,5705,427
Operating Income 9,53010,4548,07210,1017,7759,0729,73410,5417,4047,2528,0564,1828,1059,0215,4955,5049,1068,8716,9875,070
Operating Income Ratio 0.0670.0730.070.0980.0780.0830.0920.1070.0850.0780.0850.0590.1190.1390.0970.0850.1460.1630.1490.122
Total Other Income Expenses Net -808792379-438-1,339-4,5097-1,888-1,190889405367-4,980-4,474-2,928-3,972-3,634-3,776-3,303-2,669
Income Before Tax 8,72211,2498,4539,6656,4374,5649,7458,6576,2188,1448,4654,5533,1254,5472,5671,5325,4725,0953,6842,401
Income Before Tax Ratio 0.0610.0790.0730.0940.0650.0420.0920.0880.0710.0880.0890.0640.0460.070.0450.0240.0880.0940.0790.058
Income Tax Expense 2,5552,6242,4992,3312,0553,8042,9342,7471,8872,2572,3351,096746978577-881,8721,7371,367849
Net Income 6,1668,5925,8957,1194,2856046,6985,7394,0135,5435,6563,1212,0903,2321,7451,5033,3333,0422,2081,543
Net Income Ratio 0.0430.060.0510.0690.0430.0060.0630.0580.0460.060.060.0440.0310.050.0310.0230.0540.0560.0470.037
EPS 458.97636.82429.04516.17310.6943.79485.64416.16290.99401.85410.1226.3151.6234.35126.55109241.6220.5157.9110.4
EPS Diluted 458.97636.82429.04516.17310.6943.79485.64416.16290.99401.85410.1226.3151.6234.35126.55109241.6220.5157.9110.4
EBITDA 15,27716,31214,05615,91012,52014,58215,90116,10012,46114,60715,1739,57112,69812,7349,1378,10511,22811,4579,3167,600
EBITDA Ratio 0.1070.1140.1220.1540.1260.1330.150.1630.1430.1580.160.1360.1860.1970.1620.1250.180.210.1990.182